This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

ACCC granted leave to intervene in Epic-Apple relief phase in Australia

( April 21, 2026, 06:44 GMT | Official Statement) -- MLex Summary: Australia's antitrust regulator has received court approval to intervene in Epic Games’ proceedings targeting Apple’s app store practices, the watchdog has announced. In a statement on Tuesday, the Australian Competition & Consumer Commission said it has been granted leave by the Federal Court to intervene in the proceedings in relation to the relief to be ordered by the court. The regulator said it hopes to assist the court by “putting submissions that recognize the public interest in the promotion of competitive digital services markets and the broad public interest nature of the remedial orders that the court may make.” The relief hearings follow a 2025 ruling that found that Apple had misused its market power. The hearings are scheduled to start on April 28.Statement follows.ACCC granted leave to intervene in Epic v Apple proceedings...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections